Article Name Medtech innovation
SimBioSys Earns Third FDA Clearance for TumorSight™ Viz
AI-Powered 3D Surgical Planning Tool Advances Precision Breast Cancer Surgery with Latest Regulatory Milestone
10th July, 2025
VISIE Executes First Pin-Free Knee Bone Cuts Using Spatial Computing
Breakthrough Procedure Marks a Milestone in Orthopedic Surgery with Pin-Free Navigation and Augmented Reality-Driven Precision
10th July, 2025
U.S. FDA Grants Breakthrough Device Designation to Artera’s AI-Powered Prostate Cancer Decision Support Tool
Innovative software platform leverages artificial intelligence to personalize therapy decisions and improve clinical outcomes for prostate cancer patients.
10th July, 2025
Mann Eye Institute Unveils Pioneering Treatment for Dry AMD
New Therapeutic Breakthrough Offers Hope for Patients with Geographic Atrophy, the Advanced Form of Dry Age-Related Macular Degeneration
10th July, 2025
Medtronic Treats First Patient in SPYRAL GEMINI Multi-Organ Pilot Study
Study to Evaluate Renal Denervation Therapy’s Potential Benefits Beyond Hypertension Across Multiple Organ Systems
10th July, 2025
Cerapedics Treats First U.S. Patient with PearlMatrix™ Following FDA Approval
Milestone Marks Commercial Launch of P-15 Peptide-Enhanced Bone Graft for Use in Spinal Fusion Procedures
09th July, 2025
MediView Launches Multicenter Study to Validate XR90™ Extended Reality Surgical Navigation
Study to Evaluate Accuracy and Clinical Impact of XR-Guided Soft Tissue Biopsy Across Leading U.S. Medical Centers
09th July, 2025
Companion Spine to Acquire Paradigm Spine GmbH and Coflex®, CoFix® Implant Assets from Xtant Medical
Strategic Acquisition Expands Companion Spine’s Portfolio in Motion-Preserving, Minimally Invasive Spine Therapies
09th July, 2025
Rain Eye Drops Launches First-Ever Dispenser Aid for Single-Use Eye Drops
Innovative Device Enhances Ease, Precision, and Accessibility for Patients Using Preservative-Free Eye Medications
09th July, 2025
Eko CORE 500® Wins Red Dot Design Award for Product Innovation
Next-Generation Digital Stethoscope Recognized for Excellence in Design, Usability, and Clinical Impact
09th July, 2025
Cochlear Unveils World’s First Smart Cochlear Implant System
Revolutionary Implant Integrates Sensor-Driven Technology and Cloud Connectivity to Enhance Hearing Outcomes and Patient Monitoring
09th July, 2025
JenaValve Showcases Live Trilogy™ THV Implant Procedures at New York Valves 2025
Breakthrough transcatheter aortic valve technology for aortic regurgitation and stenosis featured in front of global clinical audience during premier interventional cardiology event.
08th July, 2025
MicroGenDX Revolutionizes Infectious Disease Detection with 24-Hour NGS Testing Platform
Pioneering next-generation sequencing technology delivers rapid, accurate pathogen identification to accelerate targeted treatment and improve patient outcomes across clinical settings.
08th July, 2025
Boston Scientific Secures FDA Approval for Expanded Labeling of FARAPULSE™ PFA System
Milestone enhances clinical use of the FARAPULSE™ Pulsed Field Ablation platform for treatment of atrial fibrillation, strengthening its role in next-generation cardiac electrophysiology.
08th July, 2025
Alcon to Acquire LumiThera, Expanding Retinal Portfolio with Breakthrough AMD Therapy
Acquisition adds FDA-cleared Valeda® Light Delivery System to Alcon’s pipeline, targeting early and intermediate dry age-related macular degeneration through photobiomodulation technology
08th July, 2025
Lifeforce and Toku Partner to Revolutionize Preventive Health with AI-Driven Retinal Scans
Integration of Toku’s retinal imaging technology with Lifeforce’s longevity medicine platform aims to slow aging and reduce cardiovascular risk through early, personalized insights.
08th July, 2025
Morphic Medical Secures CE Mark for RESET® Endoscopic Therapy Device
Regulatory milestone paves the way for expanded access to Morphic’s non-implant, incisionless solution for treating acid reflux and related gastrointestinal disorders across Europe.
08th July, 2025
BioNxt Advances Sublingual Cladribine Program Toward Next Phase for MS Treatment
Innovative thin-film formulation of cladribine moves forward as BioNxt prepares for next-stage development in multiple sclerosis therapy, aiming to enhance patient convenience and treatment adherence.
07th July, 2025
Medtech Special
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer